Drs. Yunda Huang, Maria Lemos, Bo Zhang and Karsten Eichholz were recently awarded coveted R01 grants from the National ...
After the FDA placed two of its next-gen HIV drugs on clinical hold last June, Gilead Sciences has now terminated one of the ...
In a paper published today in the Journal of Clinical Investigation, a research team at Johns Hopkins Medicine and the Johns ...
Beyond both being viruses, HIV-1 and SARS-CoV-2 don't seem to have a lot in common. HIV-1 is a retrovirus that integrates ...
But for Rockefeller virologist Theodora Hatziioannou, the viruses have one very important thing in common: They both cause ...
Theodora Hatziioannou used her expertise on HIV-1 to gain insights into SARS-Co-V-2, and vice versa. The potential ...